CUV 0.00% $14.30 clinuvel pharmaceuticals limited

News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-111

  1. 22,370 Posts.
    lightbulb Created with Sketch. 485

    First US Patients to be treated with SCENESSE; US insurance companies initiate coverage of SCENESSE® f or the first American patients diagnosed with erythropoietic protoporphyria (EPP)
    https://hotcopper.com.au/data/attachments/2104/2104774-e8b23d2016b42e576bc87d8c53a83c29.jpg
    http://www.asx.com.au/asxpdf/20200416/pdf/44gzrwnhjckpzs.pdf



    Al these Shorters Lolbiggrin.pngsmile.pngbiggrin.pngsmile.pngbiggrin.png

    This is a Stock with Which you can -EARLIER- SAVE your RETIREMENT!!!
    (if I wouldn't have "already")
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.